HH the Amir received the Chairman and members of the Board of Directors of CAN Campaign Kuwait

May 30, 2018

His Highness the Amir Sheikh Sabah Al-Ahmad Al- Jaber Al-Sabah received the Board of Directors of the CAN Campaign in Kuwait led by Dr. Abdulrahman Al- Awadi, Chairman of the Board, Dr. Khalid Ahmed Al Saleh, Vice President, Dr. Rashid Al-Hamad and Dr. Ali Al-Saif. They presented to His Highness the Amir the annual report of CAN Campaign which is under the auspices of His Highness the Amir for the last six years. His Highness thanked them for their efforts in the campaign against cancer and the promotion of healthy lifestyle which has benefitted the citizens and residents of the State of Kuwait. On the same occasion, they presented a memento to express their deep gratitude to His Highness the Amir for his support to awareness activities and belief in the importance of public health.


QCS campaign calls for early detection of bowel cancer

 26 Jul 2018

DOHA: Qatar Cancer Society (QCS) in cooperation with Primary Health Care Corporation (PHCC) has launched a campaign to encourage the early detection of bowel cancer as part of the ‘Screen for Life’ national programme. Dr. Khalid bin Jabor Al Thani, Chairman of QCS, visited the bowel cancer screening suite at Leabaib health centre. Bowel cancer screening targets men and women aged 50 to 74 years. Dr. Al Thani said that the new campaign aims to spread and promote the culture of early detection of bowel cancer which is one of the most common cancers in Qatar. Dr. Al Thani also called individuals between the age of 50 and 74 years take early screening for bowel screening. Further, according to Dr. Al Thani, the positive impact of continuous awareness activities about prevention and early detection of different types of cancers could be seen in another three years of time.

 https://thepeninsulaqatar.com/article/26/07/2018/QCScampaign- calls-for-early-detection-of-bowel-cancer 

Health forum launches ‘Every Voice Matters’ cancer initiative
July 25, 2018

RIYADH — Around the world, men’s life expectancy continues to be lower compared to women, in part due to them being less likely to visit a doctor. For men, prostate cancer is the second most common cancer in the world and third most common in Saudi Arabia. Currently more than 8% of the Kingdom’s population is over the age of 55 - within the age group at risk of prostate cancer - this number is expected to increase as the population continues to age.

The current knowledge gap in patient care was addressed during a panel discussion ‘Understanding Prostate Cancer patient needs’ held during the Arab League for Patients Organizations Forum in Egypt. The forum also saw the launch of the ‘Every Voice Matters’ initiative. ‘Every Voice Matters’ aims to give prostate cancer patients a voice, so that their needs are heard and understood. The MENA wide initiative is endorsed by medical societies and patient organizations from across the region including Saudi Cancer Foundation (KSA); Saudi Urology Association (KSA); Emirates Urology Society (UAE); Friends of Cancer Patients (UAE); Egyptian Urology Association (Egypt); Can Survive (Egypt), Lebanese Medical Oncology Society (Lebanon); and Lebanese Urology Society (Lebanon). During Phase one of the initiative, a prostate cancer patient survey will be conducted by IPSOS (independent research agency) in Saudi Arabia, Lebanon, UAE, and Egypt. The results are expected to be announced by November 2018. Phase two of the initiative will see cross industry collaboration and activities to address needs identified by the survey.

Dr. Mohamed Elsayes, Medical Director of Saudi Cancer Foundation said: “Our key mission is to raise awareness of cancer and fight cancer on all fronts through all possible direct and indirect channels. We believe that understanding patients’ needs will allow us to drive action in the right direction to meet those needs.”

“The cancer care ecosystem is complex involving many stakeholders – treating physicians, patients’ family and friends, patient organizations, government and pharmaceutical companies - who often don’t engage with the patient directly or collaborate among themselves.” Dr. Elsayes elaborating the benefits of ‘Every Voice Matters’ initiative, said: “Having data driven insights of what prostate cancer patients need the most we will allow us to identify areas for collaboration among all stakeholders and to advance patient care.”

‘Every Voice Matters’ gives patients the opportunity to share their story on how prostate cancer has affected their life, so men fighting the disease can receive the support that they need.